ASND
Price
$138.31
Change
-$7.43 (-5.10%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
8.72B
71 days until earnings call
ORMP
Price
$2.52
Change
-$0.05 (-1.95%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
103.6M
78 days until earnings call
Ad is loading...

ASND vs ORMP

Header iconASND vs ORMP Comparison
Open Charts ASND vs ORMPBanner chart's image
Ascendis Pharma A/S
Price$138.31
Change-$7.43 (-5.10%)
Volume$4.72K
Capitalization8.72B
Oramed Pharmaceuticals
Price$2.52
Change-$0.05 (-1.95%)
Volume$2.6K
Capitalization103.6M
ASND vs ORMP Comparison Chart
Loading...
ASND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ASND vs. ORMP commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASND is a StrongBuy and ORMP is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (ASND: $145.74 vs. ORMP: $2.57)
Brand notoriety: ASND and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ASND: 70% vs. ORMP: 113%
Market capitalization -- ASND: $8.72B vs. ORMP: $103.6M
ASND [@Biotechnology] is valued at $8.72B. ORMP’s [@Biotechnology] market capitalization is $103.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $383.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASND’s FA Score shows that 0 FA rating(s) are green whileORMP’s FA Score has 1 green FA rating(s).

  • ASND’s FA Score: 0 green, 5 red.
  • ORMP’s FA Score: 1 green, 4 red.
According to our system of comparison, ORMP is a better buy in the long-term than ASND.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASND’s TA Score shows that 5 TA indicator(s) are bullish while ORMP’s TA Score has 4 bullish TA indicator(s).

  • ASND’s TA Score: 5 bullish, 6 bearish.
  • ORMP’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both ASND and ORMP are a bad buy in the short-term.

Price Growth

ASND (@Biotechnology) experienced а -6.92% price change this week, while ORMP (@Biotechnology) price change was +22.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.84%. For the same industry, the average monthly price growth was -7.68%, and the average quarterly price growth was -7.37%.

Reported Earning Dates

ASND is expected to report earnings on May 21, 2025.

ORMP is expected to report earnings on May 28, 2025.

Industries' Descriptions

@Biotechnology (+0.84% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ASND($8.72B) has a higher market cap than ORMP($104M). ORMP YTD gains are higher at: 6.198 vs. ASND (5.862). ORMP has higher annual earnings (EBITDA): 9.44M vs. ASND (-319.82M). ASND has more cash in the bank: 626M vs. ORMP (142M). ORMP has less debt than ASND: ORMP (429K) vs ASND (789M). ASND has higher revenues than ORMP: ASND (327M) vs ORMP (0).
ASNDORMPASND / ORMP
Capitalization8.72B104M8,387%
EBITDA-319.82M9.44M-3,389%
Gain YTD5.8626.19895%
P/E RatioN/A22.91-
Revenue327M0-
Total Cash626M142M441%
Total Debt789M429K183,916%
FUNDAMENTALS RATINGS
ASND vs ORMP: Fundamental Ratings
ASND
ORMP
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
69
Overvalued
PROFIT vs RISK RATING
1..100
94100
SMR RATING
1..100
10081
PRICE GROWTH RATING
1..100
4243
P/E GROWTH RATING
1..100
10032
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORMP's Valuation (69) in the Pharmaceuticals Other industry is in the same range as ASND (91) in the Biotechnology industry. This means that ORMP’s stock grew similarly to ASND’s over the last 12 months.

ASND's Profit vs Risk Rating (94) in the Biotechnology industry is in the same range as ORMP (100) in the Pharmaceuticals Other industry. This means that ASND’s stock grew similarly to ORMP’s over the last 12 months.

ORMP's SMR Rating (81) in the Pharmaceuticals Other industry is in the same range as ASND (100) in the Biotechnology industry. This means that ORMP’s stock grew similarly to ASND’s over the last 12 months.

ASND's Price Growth Rating (42) in the Biotechnology industry is in the same range as ORMP (43) in the Pharmaceuticals Other industry. This means that ASND’s stock grew similarly to ORMP’s over the last 12 months.

ORMP's P/E Growth Rating (32) in the Pharmaceuticals Other industry is significantly better than the same rating for ASND (100) in the Biotechnology industry. This means that ORMP’s stock grew significantly faster than ASND’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ASNDORMP
RSI
ODDS (%)
Bearish Trend 4 days ago
74%
Bearish Trend 4 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
78%
Bearish Trend 4 days ago
88%
Momentum
ODDS (%)
Bearish Trend 4 days ago
74%
Bullish Trend 4 days ago
81%
MACD
ODDS (%)
Bearish Trend 4 days ago
65%
Bullish Trend 4 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
74%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
84%
Advances
ODDS (%)
Bullish Trend 11 days ago
72%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 8 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
78%
Aroon
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 4 days ago
83%
View a ticker or compare two or three
Ad is loading...
ASND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
XPND29.450.33
+1.12%
First Trust Expanded Technology ETF
FBOT28.150.29
+1.04%
Fidelity Disruptive Automation ETF
RDVY59.860.60
+1.01%
First Trust Rising Dividend Achiev ETF
TEQI41.910.36
+0.88%
T. Rowe Price Equity Income ETF
BBHY46.390.10
+0.22%
JPMorgan BetaBuilders $ HY Corp Bnd ETF

ASND and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASND has been loosely correlated with ORMP. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ASND jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASND
1D Price
Change %
ASND100%
-3.81%
ORMP - ASND
37%
Loosely correlated
+9.36%
NUVL - ASND
35%
Loosely correlated
-2.56%
AMRN - ASND
35%
Loosely correlated
-0.80%
AXON - ASND
34%
Loosely correlated
+5.43%
CASI - ASND
33%
Poorly correlated
-2.66%
More